{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T16:51:37Z","timestamp":1785689497133,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijrobp.2024.06.019","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T17:13:17Z","timestamp":1720026797000},"page":"1353-1362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Optimizing Organ-Preservation Strategies Through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results From the CROC Multi-Institutional Phase 2 Clinical Trial"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2713-4661","authenticated-orcid":false,"given":"Chikatoshi","family":"Katada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Yoshii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako Eguchi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoo","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutoshi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasaburo","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.06.019_bib0001","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Esophageal and Esophagogastric Junction Cancers Version 2. 2023. \u00a9 National Comprehensive Cancer Network, Inc. 2023. Accessed December 3, 2023. https:\/\/www.NCCN.org"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0002","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10388-023-00993-2","article-title":"Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part1","volume":"20","author":"Kitagawa","year":"2023","journal-title":"Esophagus"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0003","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/cas.12274","article-title":"Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma","volume":"104","author":"Hara","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0004","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/bjc.2016.350","article-title":"Phase II study of chemoselection with docetaxel plus cisplatin and 5\u2013fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer","volume":"115","author":"Yokota","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(24)00745-1","article-title":"Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial","volume":"404","author":"Kato","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0006","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejca.2010.09.009","article-title":"Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial","volume":"47","author":"Burmeister","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/doy078","article-title":"Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial","volume":"32","author":"von Dobeln","year":"2019","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0008","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejca.2017.04.027","article-title":"Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): long-term results of a controlled randomised trial","volume":"81","author":"Stahl","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0009","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0360-3016(03)00585-6","article-title":"Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T (2-3) N (any) M (0) squamous cell carcinoma of the esophagus","volume":"57","author":"Hironaka","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2009.02.086","article-title":"Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus","volume":"75","author":"Ariga","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0011","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1245\/s10434-014-4337-7","article-title":"Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy","volume":"22","author":"Matsuda","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0012","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s10147-016-0963-3","article-title":"Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis","volume":"21","author":"Nomura","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177133","article-title":"Survival comparison between radical surgery and definitive chemoradiation in 267 esophageal squamous cell carcinomas in a single institution: a propensity-matched study","volume":"12","author":"Yamashita","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0014","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jjco\/hyx040","article-title":"Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical stage II\/III esophageal squamous cell carcinoma (JCOG1406-A)","volume":"47","author":"Nomura","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2005.01.2047","article-title":"Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm","volume":"24","author":"Urba","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0016","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1200\/JCO.2007.12.7597","article-title":"Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number","volume":"26","author":"Worden","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0017","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000455128","article-title":"Prognostic advantage of docetaxel\/cisplatin\/5\u2013fluorouracil neoadjuvant chemotherapy in clinical stage II\/III esophageal squamous cell carcinoma due to excellent control of preoperative disease and postoperative lymph node recurrence","volume":"92","author":"Yamashita","year":"2017","journal-title":"Oncology"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0018","series-title":"Japanese Classification of Esophageal Cancer","first-page":"64","year":"2022"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0019","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijrobp.2022.07.007","article-title":"A single-arm confirmatory study of definitive chemoradiation therapy including salvage treatment for clinical stage II\/III esophageal squamous cell carcinoma (JCOG0909 Study)","volume":"114","author":"Takeuchi","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10147-011-0278-3","article-title":"Predicting the effects of chemoradiotherapy for squamous cell carcinoma of the esophagus by induction chemotherapy response assessed by positron emission tomography: toward PET-response-guided selection of chemoradiotherapy or esophagectomy","volume":"17","author":"Ishihara","year":"2012","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0021","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11523-017-0540-3","article-title":"Early metabolic change after induction chemotherapy predicts histologic response and prognosis in patients with esophageal cancer: secondary analysis of a randomized trial","volume":"13","author":"Harada","year":"2018","journal-title":"Target Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0022","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1245\/s10434-020-08738-6","volume":"28","author":"Sonoda","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0023","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1245\/s10434-011-2049-9","article-title":"A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5\u2013fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907)","volume":"19","author":"Ando","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0024","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1053\/j.gastro.2021.08.007","article-title":"Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma","volume":"161","author":"Kato","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jtcvs.2008.05.016","article-title":"Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma","volume":"137","author":"Tachimori","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0026","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1067\/mtc.2002.119070","article-title":"Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy","volume":"123","author":"Swisher","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0027","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000018618","article-title":"Salvage esophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the esophagus","volume":"15","author":"Meunier","year":"1998","journal-title":"Dig Surg"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0028","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjsurg.2004.06.003","article-title":"Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer","volume":"188","author":"Nakamura","year":"2004","journal-title":"Am J Surg"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0029","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00268-009-0331-9","article-title":"Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy","volume":"34","author":"Takeuchi","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1055\/s-2008-1077480","article-title":"Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma","volume":"40","author":"Yano","year":"2008","journal-title":"Endoscopy"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0031","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/dote.12037","article-title":"Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chmoradiotherapy for stage IB, II, and III esophageal squamous cell cancer","volume":"27","author":"Makazu","year":"2014","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0032","doi-asserted-by":"crossref","first-page":"22135","DOI":"10.18632\/oncotarget.14029","article-title":"A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer","volume":"8","author":"Yano","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0033","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13014-016-0604-z","article-title":"Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer","volume":"11","author":"Hatogai","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.06.019_bib0034","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624007521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624007521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T23:27:46Z","timestamp":1731626866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624007521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0360301624007521"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.06.019","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing Organ-Preservation Strategies Through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results From the CROC Multi-Institutional Phase 2 Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}